Balertatug
巴乐妥塔单抗
Report date: 2025/11/10 15:47:08
Base Information
Drug NameBalertatug
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSeagen Inc
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A